Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction

Int J Cardiol. 2015 Aug 15:193:53-5. doi: 10.1016/j.ijcard.2015.05.053. Epub 2015 May 12.

¹ Department of Physiology - HeartOtago, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand.
² Department of Cardiothoracic Surgery, Dunedin School of Medicine, Dunedin Hospital, Dunedin, New Zealand.
³ Department of Medicine - HeartOtago, Dunedin School of Medicine, Dunedin Hospital, Dunedin, New Zealand.
⁴ Department of Medicine - HeartOtago, Dunedin School of Medicine, Dunedin Hospital, Dunedin, New Zealand; NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
⁵ Department of Physiology - HeartOtago, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: [email protected].
⁶ Department of Physiology - HeartOtago, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: [email protected].

No abstract available

Keywords: Diabetes; Diastolic dysfunction; Phospholamban; Preserved ejection fraction; SERCA2a.

Publication types